EUVIMEDOdkrijte EUVIMED
Crossref

Treatment of cisplatin-induced olfactory aversion based on selection logic: A novel approach.

Yong Yu iD, Yoshihisa Koyama iD, Shoichi Shimada iD

Behavioral Neuroscience · 2026

DOI: 10.1037/bne0000653 ↗

At a glance

Journal article in Behavioral Neuroscience, 2026. Written by Yong Yu and 2 co-authors. Institution: Department of Neuroscience and Cell Biology, Graduate School of Medicine, University of Osaka. Major MEDLINE topics: Cisplatin, Avoidance Learning, Olfactory Perception, Smell. Cited 1 times so far (Crossref). Funded by: University of Osaka, Shandong Government, Shandong First Medical University.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

Povzetek ni na voljo.

Subjects

MeSH terms (MEDLINE)

CisplatinAvoidance LearningOlfactory PerceptionSmellAnimalsMaleMiceOdorantsChoice BehaviorPentanolsBenzaldehydesAntineoplastic Agents

Substances

CisplatinPentanolsBenzaldehydesAntineoplastic Agentsisoamyl acetatebenzaldehyde

Authors and institutions

  • Department of Neuroscience and Cell Biology, Graduate School of Medicine, University of Osaka.

ORCID profiles: Yong Yu, Yoshihisa Koyama, Shoichi Shimada

Funding

  • University of Osaka
  • Shandong Government
  • Shandong First Medical University

Cite

APA

Yu, Y., Koyama, Y., & Shimada, S. (2026). Treatment of cisplatin-induced olfactory aversion based on selection logic: A novel approach. Behavioral Neuroscience. https://doi.org/10.1037/bne0000653

Vancouver

Yu Y, Koyama Y, Shimada S. Treatment of cisplatin-induced olfactory aversion based on selection logic: A novel approach. Behavioral Neuroscience. 2026. doi:10.1037/bne0000653

BibTeX
@article{Yu2026,
  author = {Yu, Yong and Koyama, Yoshihisa and Shimada, Shoichi},
  title = {Treatment of cisplatin-induced olfactory aversion based on selection logic: A novel approach},
  journal = {Behavioral Neuroscience},
  year = {2026},
  doi = {10.1037/bne0000653}
}
Start for free →